Because the aggrecan, fibrillin, and MMP-3 peptides induced the strongest proliferative responses, these peptides were selected to analyze cytokine production of PBMC from patients with JIA and healthy controls upon peptide incubation. The gene discussed is ACAN; the disease is juvenile idiopathic arthritis.